IRAK1 and hepatocellular carcinoma: This work was undergone to provide potential diagnostic biomarkers and therapeutic targets for hepatocellular carcinoma, and to afford hit natural compounds as potential IRAK1 inhibitors and suppressors of IRAK1-related pathways to be used in targeted therapy.